“We think this is an egregious situation of DePuy’s failure to take any action about a clear problem with the performance of its hip replacement system,” Strum attorney Peter J. Flowers said in an interview. “It’s the classic case of profits over safety.”
Chicago, Illinois (PRWEB) March 15, 2013
Coming on the heels of an $8.3 million loss just last week in California, in the first trial over its recalled metal hip implant, according to Bloomberg News on March 11th, Johnson & Johnson now faces a second DePuy ASR jury trial that will consider whether its metal hip design was defective in Carol Strum v. DePuy Orthopaedics, Inc., a Foreign Corporation, and Premier Orthopaedic Sales, Inc., an Illinois Corporation, Case Number 2011 L 009352 (Circuit Court of Cook County, Illinois).
According to the American Association of Orthopaedic Surgeons, 200,000 or more hip replacement surgeries are performed each year in the United States. In recent months, metal hip replacement devices have come under increased scrutiny by the Food and Drug Administration (FDA) for the high number of adverse events reported. The DePuy ASR XL Acetabular System and the DePuy ASR Hip Resurfacing System were recalled in August of 2010 after being on the market since July 2003. The DePuy recall occurred after multiple studies showed that the medical devices failed to perform as intended.
Flowers and his firm, Meyers and Flowers, represent DePuy hip implant side effects claimants and surviving family members across the country. On behalf of these clients, Flowers has filed lawsuits against parties involved in the manufacturing, marketing and distribution of these dangerous metal hip implants. In his DePuy hip lawsuits, Flowers alleges that the ASR devices cause serious side effects, ranging from implant failure and revision surgery to permanent disability and even death, and that DePuy failed to adequately warn victims of the risks associated with its metal hip implants.
A nationally known, aggressive trial lawyer, Peter J. Flowers has led many coordinated litigations across the country, leading the fight against large manufacturers who place dangerous and defective drugs and medical devices into the marketplace. Flowers has served on multiple Plaintiffs Steering Committees and tried major pharmaceutical and medical device cases to successful jury verdicts. Some of his most notable legal appointments include:
- Appointed to serve on the Plaintiffs Executive Committee in In Re Biomet M2a Magnum Hip Implant Products Liability Litigation, MDL 2391 (South Bend, Indiana);
- Appointed to serve as Liaison Counsel in In Re: Zimmer NexGen Implants Products Liability Litigation, MDL 2272 (Chicago, Illinois)
- Appointed to serve on the Plaintiffs Executive Committee in In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL 2385 (East St. Louis, Illinois);
- Appointed to serve on the Plaintiffs Steering Committee in In Re: Ethicon, Inc. Pelvic Repair System Products Liability Litigation, MDL 2327 (Charleston, West Virginia);
- Appointed to serve as Lead Counsel in In Re: Brown v. DePuy Spine Inc, 06-0224 (Massachusetts State Court);
- Appointed to serve as Lead Counsel in In Re: DePuy ASR Litigation: 2010 L 010506 (Illinois State Court);
- Appointed to serve as Co-Lead Counsel in In Re: Actos Litigation, 2011 L 010011 (Illinois State Court);
Peter J. Flowers is proud to handle one of the largest DePuy ASR injury and wrongful death dockets in the country. For more information about Flowers or Meyers & Flowers, please visit our website.
For Press Inquiries During Trial:
Brian J. Perkins, Partner
Meyers & Flowers